1-1 By: Duncan, Moncrief S.B. No. 556 1-2 (In the Senate - Filed February 6, 2001; February 7, 2001, 1-3 read first time and referred to Committee on Health and Human 1-4 Services; March 28, 2001, reported adversely, with favorable 1-5 Committee Substitute by the following vote: Yeas 5, Nays 0; 1-6 March 28, 2001, sent to printer.) 1-7 COMMITTEE SUBSTITUTE FOR S.B. No. 556 By: Bernsen 1-8 A BILL TO BE ENTITLED 1-9 AN ACT 1-10 relating to prices of prescription drugs provided to certain 1-11 Medicare recipients by certain pharmacies participating in the 1-12 Medicaid vendor drug program. 1-13 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: 1-14 SECTION 1. Subchapter B, Chapter 32, Human Resources Code, 1-15 is amended by adding Section 32.0462 to read as follows: 1-16 Sec. 32.0462. SENIOR DRUG ASSISTANCE PROGRAM. (a) In this 1-17 section, "participant" means a provider in the vendor drug program 1-18 who chooses to participate in the senior drug assistance program. 1-19 (b) The department by rule shall develop and implement a 1-20 voluntary pricing program under which a provider in the vendor drug 1-21 program may agree to provide to a Medicare recipient eligible under 1-22 Subsection (c) prescription drugs available to a recipient of 1-23 medical assistance under the vendor drug program at a price not 1-24 greater than the lesser of: 1-25 (1) the usual and customary price for the drug; or 1-26 (2) the sum of: 1-27 (A) the amount of reimbursement the provider 1-28 would have received for providing the drug to a recipient of 1-29 medical assistance; and 1-30 (B) an administrative fee of $1. 1-31 (c) A Medicare recipient is eligible to receive a 1-32 prescription drug available to a recipient of medical assistance 1-33 under the vendor drug program at a reduced price in accordance with 1-34 the senior drug assistance program only if the recipient does not 1-35 have insurance coverage or other health benefit plan coverage that 1-36 provides pharmaceutical benefits for that drug. 1-37 (d) The department may provide a participant with a rebate 1-38 from the department for each prescription drug provided to an 1-39 eligible Medicare recipient at a reduced price under the senior 1-40 drug assistance program. The department shall determine the amount 1-41 of the rebate based on the amount of funds available to the 1-42 department for that purpose. 1-43 (e) The department shall negotiate rebate agreements and 1-44 other terms with pharmaceutical companies whose products are 1-45 covered under the vendor drug program to provide the rebates 1-46 prescribed by Subsection (d). 1-47 (f) If the savings or other sources of funding obtained 1-48 through negotiations with pharmaceutical companies under Subsection 1-49 (e) exceed the cost of implementing, administrating, and operating 1-50 the senior drug assistance program, the department may return 1-51 excess rebate revenue to participating pharmaceutical companies 1-52 based on an equitable method of distribution determined by the 1-53 department. 1-54 (g) In implementing the senior drug assistance program under 1-55 this section, the department shall: 1-56 (1) require an eligible Medicare recipient, as a 1-57 condition of receiving a reduced price under the senior drug 1-58 assistance program, to: 1-59 (A) present the recipient's Medicare card and 1-60 any other documentation required by the department to confirm the 1-61 recipient's eligibility for the reduced price; and 1-62 (B) provide a prescription for the drug that 1-63 names the recipient; and 1-64 (2) ensure that information concerning prices that may 2-1 be charged under the senior drug assistance program is readily 2-2 available to participants. 2-3 (h) The department shall take all possible action, including 2-4 any administrative action available to the department in connection 2-5 with the operation of any department program, to encourage: 2-6 (1) providers in the vendor drug program to 2-7 participate in the senior drug assistance program; and 2-8 (2) pharmaceutical companies to negotiate rebate 2-9 agreements under Subsection (e) to enable the department to 2-10 successfully implement the senior drug assistance program. 2-11 (i) The department shall: 2-12 (1) monitor provider participation in the senior drug 2-13 assistance program; 2-14 (2) evaluate the effect of the senior drug assistance 2-15 program on the availability of prescription drugs to eligible 2-16 Medicare recipients; and 2-17 (3) develop recommendations for improving the 2-18 availability of prescription drugs to eligible Medicare recipients. 2-19 (j) Not later than January 1 of each year, the department 2-20 shall submit a report to the legislature containing the information 2-21 obtained and developed by the department under Subsection (i). 2-22 (k) Pharmacies may participate in the senior drug assistance 2-23 program before the department successfully negotiates rebate 2-24 agreements under Subsection (e) with pharmaceutical companies that 2-25 sell prescription drugs. The department shall favorably note any 2-26 participation by pharmacies under this subsection to the 2-27 legislature during the next legislative session. 2-28 SECTION 2. If, before implementing any provision of this 2-29 Act, a state agency determines that a waiver or authorization from 2-30 a federal agency is necessary for implementation of that provision, 2-31 the agency affected by the provision shall request the waiver or 2-32 authorization and may delay implementing that provision until the 2-33 waiver or authorization is granted. If the state agency determines 2-34 that a waiver or authorization is necessary, the agency shall 2-35 submit an implementation plan to the legislature during the next 2-36 regular legislative session or to the Legislative Budget Board 2-37 during the interim on receipt of the waiver or authorization and 2-38 before its implementation. 2-39 SECTION 3. This Act takes effect September 1, 2001. 2-40 * * * * *